Truvada
Gilead Sciences Proceeds with $247 Million Settlement in HIV Antitrust Case Following Trial Victory
Anika Sharma
Despite Gilead Sciences and Teva Pharmaceutical Industries emerging victorious in a high-stakes antitrust trial related to HIV drugs earlier this ...
Gilead and Teva were acquitted in a $3.6 billion trial involving alleged ‘pay-for-delay’ schemes
SG Tylor
Gilead Sciences and Teva have been exonerated by a California court jury in a lawsuit accusing them of colluding to ...
